|Day's range||0.0200 - 0.0300|
Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.
Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...
Moderna (MRNA) closed the most recent trading day at $149.42, moving +0.84% from the previous trading session.